Concepedia

Publication | Open Access

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden

DOIFull Paper Access

11

Citations

8

References

2021

Year

Kyla A. McKay, Fredrik Piehl, Simon Englund, Anna He, Annette Langer‐Gould, Jan Hillert, Thomas Frisell
JAMA Network Open

Abstract

This case-control study examines the risk of severe COVID-19 infection in individuals with multiple sclerosis who were receiving rituximab.

References

YearCitations

Page 1